Related Experiment Videos
TGF-beta knockout and dominant-negative receptor transgenic mice
1Laboratory of Chemoprevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-5055, USA. Letterij@pop.nci.nih.gov
Summary
Mouse models using homologous recombination and transgenic technologies reveal distinct roles for TGF-beta isoforms in development. TGF-beta1 is crucial for immune system modulation, affecting immune cell development and function.
Area of Science:
- Molecular Biology
- Immunology
- Developmental Biology
Background:
- Transforming growth factor-beta (TGF-beta) signaling is critical for numerous physiological processes.
- Understanding the specific roles of TGF-beta isoforms requires in vivo models.
Purpose of the Study:
- To investigate the physiological functions of mammalian TGF-beta isoforms using mouse models.
- To elucidate the regulatory mechanisms of TGF-beta in intact animals.
- To explore novel methods for disrupting TGF-beta signaling in specific tissues and cells.
Main Methods:
- Utilizing homologous recombination and transgenic technologies to create mouse models.
- Generating mice with null mutations for specific TGF-beta isoforms.
- Developing transgenic mice with dominant-negative mutant TGF-beta receptors for targeted pathway disruption.
Main Results:
- Null mutations for TGF-beta isoforms demonstrate unique, non-overlapping developmental functions.
- TGF-beta1 null mice exhibit significant immune system modulation, including altered immune cell development, activation, and function.
- These models provide insights into the complex roles of TGF-beta in vivo.
Conclusions:
- Each TGF-beta isoform plays a distinct role in mammalian development.
- TGF-beta1 is essential for proper immune system regulation.
- Transgenic approaches offer powerful tools to dissect TGF-beta signaling pathways.